CRIS vs CTVA · rev $10.9M vs P/E 42, rev $16.91B
Curis Inc (CRIS) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Curis Inc (CRIS) is a biotechnology company listed on US.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported CRIS revenue for 2024-12-31 was $10.9M. Net income was -$43.4M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CRIS currently screens at market cap $22.1M.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
CRIS currently screens at market cap $22.1M. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the CRIS and CTVA stock pages for the full models.
Not investment advice.